pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
MINZOYA
MINZOYA (LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS BISGLYCINATE)
Lupin Ltd
0
catalysts
Preclinical
MIRA-55
Anxiety Disorders
$MIRA
MIRA PHARMACEUTICALS, INC.
0
catalysts
Phase 2
MIT-001
Oral Mucositis
MitoImmune Therapeutics Inc
0
catalysts
MITOXANTRONE
MITOXANTRONE (MITOXANTRONE)
HOSPIRA
0
catalysts
← prev
page 108 of 231
next →
131
Pain
89
Neurology
1
Phase 2
MIV-711
Osteoarthritis
Medivir AB
0
catalysts
MIXED SALTS OF A SINGLE-ENTITY AMPHETAMINE PRODUCT
MIXED SALTS OF A SINGLE-ENTITY AMPHETAMINE PRODUCT (DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE)
SpecGx LLC
0
catalysts
Phase 3
MK-1406
Pandemic Influenza
$MRK
Merck & Co., Inc.
0
catalysts
Phase 2
MK-2214
Alzheimer's Disease
$MRK
Merck & Co., Inc.
0
catalysts
Phase 2
MK-3795
Von Hippel-Lindau Syndrome
$MRK
Merck & Co., Inc.
0
catalysts
Phase 2
MK-6194
Ulcerative Colitis
$MRK
Merck & Co., Inc.
0
catalysts
Marketed
ML-061
Docivyx (docetaxel)
Adenocarcinoma Of The Gastroesophageal Junction
Meridian Laboratories Inc
0
catalysts
Preclinical
MLN-33
Melanoma
$CNBX
CNBX Pharmaceuticals Inc.
0
catalysts
Phase 2
MNV-101
Pearson Syndrome
Minovia Therapeutics Ltd
0
catalysts
Phase 2
MNV-201
Pearson Syndrome
Minovia Therapeutics Ltd
0
catalysts
Phase 1
MO-03
Metastatic Renal Cell Carcinoma
Osel Inc
0
catalysts
Phase 1
MOMA-313
Metastatic Breast Cancer
Moma Therapeutics Inc
0
catalysts
Preclinical
MOMA-989
Unspecified Cancer
Moma Therapeutics Inc
0
catalysts
MOMETASONE FUROATE MONOHYDRATE
MOMETASONE FUROATE MONOHYDRATE (MOMETASONE FUROATE MONOHYDRATE)
AUROBINDO PHARMA
0
catalysts
MONTELUKAST
MONTELUKAST (MONTELUKAST)
MACLEODS PHARMS LTD
0
catalysts
Phase 2
MORF-057
Crohn's Disease (Regional Enteritis)
Eli Lilly and Co
0
catalysts
MOXIFLOXACIN OPHTHALMIC SOLUTION
MOXIFLOXACIN OPHTHALMIC SOLUTION (MOXIFLOXACIN OPHTHALMIC SOLUTION)
ALEMBIC
0
catalysts
Preclinical
MP-004
Retinitis Pigmentosa (Retinitis)
MIRAMOON Pharma SL
0
catalysts
Phase 2
MP-0712
Neuroendocrine Tumors
$MOLN
MOLECULAR PARTNERS AG
0
catalysts
Phase 2
MP-101
dimiracetam [INN]
Amyotrophic Lateral Sclerosis
Mitochon Pharmaceuticals Inc
0
catalysts
Phase 2
MP-1032
Coronavirus Disease 2019 (COVID-19)
MetrioPharm AG
0
catalysts
Phase 2
MPB-1734
Solid Tumor
MegaPro Biomedical Co Ltd
0
catalysts
Preclinical
MPB-2354
Rheumatoid Arthritis
MegaPro Biomedical Co Ltd
0
catalysts
Phase 2
MRG-002
Gastric Cancer
Shanghai Miracogen Inc
0
catalysts
Phase 2
MRG-004A
Solid Tumor
Shanghai Miracogen Inc
0
catalysts
Phase 2
MRM-3379
Fragile X Syndrome
$MIRM
Mirum Pharmaceuticals, Inc.
0
catalysts
